Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Sell
36
OSTX Quote, Financials, Valuation and Earnings
Last price:
$1.56
Seasonality move
:
-19.02%
Day range:
$1.52 - $1.63
52-week range:
$1.12 - $7.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
15.01x
Volume:
891.6K
Avg. volume:
462.8K
1-year change:
-69.73%
Market cap:
$54.6M
Revenue:
--
EPS (TTM):
-$0.82
Analysts' Opinion
-
Consensus RatingOS Therapies, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $11.49, OS Therapies, Inc. has an estimated upside of 641.16% from its current price of $1.55.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $6.00 representing 100% downside risk from its current price of $1.55.
Fair Value
-
According to the consensus of 3 analysts, OS Therapies, Inc. has 641.16% upside to fair value with a price target of $11.49 per share.
OSTX vs. S&P 500
-
Over the past 5 trading days, OS Therapies, Inc. has overperformed the S&P 500 by 13.88% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
OS Therapies, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
OS Therapies, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter OS Therapies, Inc. reported revenues of --.
Earnings Growth
-
OS Therapies, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter OS Therapies, Inc. reported earnings per share of -$0.22.
Enterprise value:
53.8M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.04x
EV / Free cash flow:
-4.03x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$239.5K
Return On Assets:
-294.62%
Net Income Margin (TTM):
--
Return On Equity:
-750.68%
Return On Invested Capital:
-750.68%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$5K | -$1.4K | -$239.5K | -- | -$124.9K | |
| Operating Income | -$4.9M | -$5M | -$19.7M | -$2.4M | -$6.9M | |
| EBITDA | -$4.9M | -$5M | -$19.4M | -$2.4M | -$6.8M | |
| Diluted EPS | -$0.39 | -$0.57 | -$0.82 | -$0.18 | -$0.22 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $16.1K | $2M | $2.3M | |
| Total Assets | -- | -- | $653.6K | $2M | $9M | |
| Current Liabilities | -- | -- | $9.4M | $2.6M | $4.1M | |
| Total Liabilities | -- | -- | $23.1M | $2.6M | $4.1M | |
| Total Equity | -- | -- | -$22.5M | -$707.1K | $4.7M | |
| Total Debt | -- | -- | $13.5M | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$3.1M | -$5.8M | -$12.9M | -$3.4M | -$4.7M | |
| Cash From Investing | $1.1K | -- | -$466.4K | -- | -- | |
| Cash From Financing | $2.9M | $7.6M | $13.4M | $5.1M | $3.8M | |
| Free Cash Flow | -$3.1M | -$5.8M | -$13.3M | -$3.4M | -$4.7M | |
OSTX
Sector
Market Cap
$54.6M
$28.1M
Price % of 52-Week High
22.14%
51.87%
Dividend Yield
0%
0%
Shareholder Yield
-15.38%
-1.59%
1-Year Price Total Return
-69.73%
-17.31%
Beta (5-Year)
--
0.495
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.49
200-day SMA
Sell
Level
$1.81
Bollinger Bands (100)
Sell
Level
1.66 - 2.18
Chaikin Money Flow
Sell
Level
-62.3M
20-day SMA
Sell
Level
$1.59
Relative Strength Index (RSI14)
Sell
Level
46.33
ADX Line
Sell
Level
22.09
Williams %R
Neutral
Level
-36.8421
50-day SMA
Sell
Level
$1.72
MACD (12, 26)
Sell
Level
-0.07
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
53M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-8.7166)
Sell
CA Score
(Annual)
Level (-29.2687)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (19.3183)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (0)
Revenue Forecast
Earnings per Share Forecast
Company Profile
OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Grasonville, MD.
Stock Forecast FAQ
In the current month, OSTX has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The OSTX average analyst price target in the past 3 months is $11.49.
-
Where Will OS Therapies, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that OS Therapies, Inc. share price will rise to $11.49 per share over the next 12 months.
-
What Do Analysts Say About OS Therapies, Inc.?
Analysts are divided on their view about OS Therapies, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that OS Therapies, Inc. is a Sell and believe this share price will drop from its current level to $6.00.
-
What Is OS Therapies, Inc.'s Price Target?
The price target for OS Therapies, Inc. over the next 1-year time period is forecast to be $11.49 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is OSTX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for OS Therapies, Inc. is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of OSTX?
You can purchase shares of OS Therapies, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase OS Therapies, Inc. shares.
-
What Is The OS Therapies, Inc. Share Price Today?
OS Therapies, Inc. was last trading at $1.56 per share. This represents the most recent stock quote for OS Therapies, Inc.. Yesterday, OS Therapies, Inc. closed at $1.55 per share.
-
How To Buy OS Therapies, Inc. Stock Online?
In order to purchase OS Therapies, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get OSTX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OSTX
Sector
P/E ratio
--
24.20x
PEG ratio
-0.04x
-0.01x
P/B ratio
15.01x
1.84x
Price / LTM sales
--
1.60x
Growth Metrics
OSTX
Sector
Revenue growth
--
4.51%
Earnings growth
-19.02%
10.7%
Revenue (5-year growth)
--
6.45%
Earnings forecast
-$0.14
-$0.19
Profitability
OSTX
Sector
Profitability FY 2024
-$2.8K
$3.5M
Return on invested capital
-750.68%
-32.3%
Return on assets
-294.62%
-28.57%
Return on equity
-750.68%
-38.09%
Earnings Date
Last Earnings Date
Nov
17
Next Earnings Date
Mar
31
Estimated Next Earnings Date
Feb
16
Balance Sheet
OSTX
Sector
Total cash
$1.9M
$26M
Short term investments
--
$25.7M
Total assets
$5.5M
$76.4M
Long term debt
--
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Shopify Stock a Good Buy Now?
eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…
Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
71
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
Buy
54
LGIH alert for Jan 10
LGI Homes, Inc. [LGIH] is up 13.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
